In Silico and Ultrahigh‐Throughput Screenings (uHTS) in Drug Discovery: An Overview
Debmalya Barh, Shoaib Ahmad, Atanu Bhattacharjee
Abstract
Debmalya Barh, Shoaib Ahmad, Atanu Bhattacharjee
Abstract
This chapter contains sections titled: Introduction In Silico Pharmacology and Virtual Ligand Screening for Drug Discovery Lead Discovery Using Integrative Virtual Screening Application of Microarray Technology in HTS and Drug Discovery Chemical Proteomics for Drug Discovery and Development Target and Drug Discovery Using Lipomic Profiling Drug Discovery Using Integrative Genomics Toxicogenomics in Drug Discovery and Development HTP RNAi Screening for Targeted Drug Discovery High-Throughput Screening with Stem Cells Systems Biology in Drug Discovery Conclusion References
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This chapter contains sections titled: Introduction In Silico Pharmacology and Virtual Ligand Screening for Drug Discovery Lead Discovery Using Integrative Virtual Screening Application of Microarray Technology in HTS and Drug Discovery Chemical Proteomics for Drug Discovery and Development Target and Drug Discovery Using Lipomic Profiling Drug Discovery Using Integrative Genomics Toxicogenomics in Drug Discovery and Development HTP RNAi Screening for Targeted Drug Discovery High-Throughput Screening with Stem Cells Systems Biology in Drug Discovery Conclusion References
Key concepts: Drug discovery, In silico, Computational biology, Toxicogenomics, Virtual screening, Profiling (computer programming), Drug, Biomarker discovery